An innovative clinical trial using the science of "personalized" cellular therapy has begun enrolling children and adults suffering from graft-versus-host-disease (GVHD), a life-threatening complication of bone marrow transplantation.
Cardiothoracic surgeon-researcher Manu Sancheti, MD, received the Best Scientific Poster Presentation Award at the American College of Surgeons for a study of cancer mortality risk factors for lung cancer patients after surgical resection.
Emory Johns Creek Hospital will host several dozen cancer survivors this weekend who are training to become CanCare volunteers.
In a continuation of clinical trials related to the biological benefits of massage therapy, Emory researchers are currently studying how massage may help reduce fatigue in breast cancer patients.
The Nell Hodgson Woodruff School of Nursing at Emory University recently selected Claudia Garcia and Tahsin Rajabali as recipients of its inaugural Susan D. Flynn Memorial Oncology Nursing Externship. This externship is an eight-week long paid immersion program awarded to Bachelor of Science in Nursing students who plan to pursue a career in the field of oncology nursing.
The Oncology Nursing Society has awarded Deborah Watkins Bruner, PhD, RN, FAAN, with the Distinguished Researcher Award.
Emory researchers have found that in a mouse model of chronic viral infection, a kind of traffic pileup inside the body limits how effective therapeutic antibodies can be. The results, published in Immunity, have implications for biotechnology researchers who continue to refine antibodies for therapeutic purposes.
People around the globe are commemorating World Cancer Day and raising awareness about one of the leading causes of death worldwide. This year's theme, "Not Beyond Us," focuses on solutions to the problem.
Professor Michelle Kegler, along with public health colleagues worked with the United Way of Greater Atlanta to recruit smoking households to participate in a project to create home smoking bans.
As 2014 draws to a close, the Winship Cancer Institute at Emory University is able to look back at a banner year, with record numbers of clinical trials, national recognitions for excellence and successful fundraising.